J of IMAB. 2012; 18(3):302-304
SCREENING FOR POSTSTROKE COGNITIVE IMPAIRMENT VIA MINI MENTAL STATE EXAMINATION AND MONTREAL COGNITIVE ASSESSMENT SCALE
Mirena Valkova, Boyko Stamenov, Dora Peychinska
Department of Neurology and Neurosurgery, Medical University, Pleven, Bulgaria.

ABSTRACT:
Objective: The aim of our study is to examine cognitive performance after mild stroke via Mini Mental State Examination (MMSE) and Montreal cognitive assessment scale (MoCA) and to compare the results.
Material and methods: We examined 54 patients with mild stroke (aged 52 to 72 (mean 63.17, SD 5.96); 34 males and 20 females) and 54 controls, adjusted by age, sex and education level. All subjects were tested via MMSE (Bulgarian version) and MoCa (Bulgarian version). Data was collected in the single step model at the 90th day after stroke incident for patients and at the day of obtaining informed consent for controls.
Results: Patients have poorer performance on both MMSE and MoCa than controls. MoCa has comparatively good discriminative validity and sensitivity.
Conclusions: Although MMSE is one of the classical screening tools for cognitive impairment widely used in Bulgaria, other screening tools should not be ignored. On the basis of our results, MoCa is also a good screening instrument, especially for poststroke cognitive impairment.

Key words: Mini Mental State Examination, Montreal cognitive assessment scale, ischemic stroke, cognition.

- Download FULL TEXT /PDF 540 KB/
Please cite this article as: Valkova M, Stamenov B, Peychinska D. SCREENING FOR POSTSTROKE COGNITIVE IMPAIRMENT VIA MINI MENTAL STATE EXAMINATION AND MONTREAL COGNITIVE ASSESSMENT SCALE. J of IMAB. 2012; 18(3):302-304. doi: 10.5272/jimab.2012183.302.

REFERENCES:
1. Titianova E. Ultrasound diagnostics in neurology. Sofia, COTI Press, 2006: 193
2. Campos TF, Rodrigues CA, Farias IM, Ribeiro TS, Melo LP. Comparison of instruments for sleep, cognition and function evaluation in stroke patients according to the international classification of functioning, disability and health (ICF). Rev Bras Fisioter. 2012 Jan-Feb;16(1):23-29. [PubMed] [CrossRef
3. Memória CM, Yassuda MS, Nakano EY, Forlenza OV. Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment. Int J Geriatr Psychiatry. 2012 Feb 27.  [PubMed] [CrossRef]
4. Arciniegas DB, Kellermeyer GF, Bonifer NM, Anderson-Salvi KM, Anderson CA. Screening for cognitive decline following single known stroke using the Mini-Mental State Examination. Neuropsychiatr Dis Treat. 2011; 7:189-96. [PubMed] [CrossRef]
5. Sundar U, Adwani S. Post-stroke cognitive impairment at 3 months. Ann Indian Acad Neurol. 2010 Jan;13(1):42-6. [PubMed] [CrossRef]
6. Rostrup E, Gouw AA, Vrenken H, van Straaten EC, Ropele S, Pantoni L, et al.; LADIS study group. The spatial distribution of age-related white matter changes as a function of vascular risk factors-Results from the LADIS study. Neuroimage. 2012 Apr 15;60(3):1597-607. [PubMed] [CrossRef]
7. Arntzen KA, Schirmer H, Johnsen SH, Wilsgaard T, Mathiesen EB. Carotid atherosclerosis predicts lower cognitive test results: a 7-year follow-up study of 4,371 stroke-free subjects - the tromsø study. Cerebrovasc Dis. 2012; 33(2):159-65. [PubMed] [CrossRef]
8. Sahathevan R, Brodtmann A, Donnan GA. Dementia, stroke, and vascular risk factors; a review. Int J Stroke. 2012 Jan;7(1):61-73. [PubMed] [CrossRef].